These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 7913408

  • 1. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
    Smith CD, Zhang X, Mooberry SL, Patterson GM, Moore RE.
    Cancer Res; 1994 Jul 15; 54(14):3779-84. PubMed ID: 7913408
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
    Panda D, Himes RH, Moore RE, Wilson L, Jordan MA.
    Biochemistry; 1997 Oct 21; 36(42):12948-53. PubMed ID: 9335554
    [Abstract] [Full Text] [Related]

  • 3. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
    Smith CD, Carmeli S, Moore RE, Patterson GM.
    Cancer Res; 1993 Mar 15; 53(6):1343-7. PubMed ID: 8095179
    [Abstract] [Full Text] [Related]

  • 4. Microtubule effects of welwistatin, a cyanobacterial indolinone that circumvents multiple drug resistance.
    Zhang X, Smith CD.
    Mol Pharmacol; 1996 Feb 15; 49(2):288-94. PubMed ID: 8632761
    [Abstract] [Full Text] [Related]

  • 5. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
    Bai R, Cichacz ZA, Herald CL, Pettit GR, Hamel E.
    Mol Pharmacol; 1993 Oct 15; 44(4):757-66. PubMed ID: 8232226
    [Abstract] [Full Text] [Related]

  • 6. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP.
    Clin Cancer Res; 2002 Dec 15; 8(12):3922-32. PubMed ID: 12473608
    [Abstract] [Full Text] [Related]

  • 7. Shape changes and chemokinesis of Walker 256 carcinosarcoma cells in response to colchicine, vinblastine, nocodazole and taxol.
    Keller HU, Zimmermann A.
    Invasion Metastasis; 1986 Dec 15; 6(1):33-43. PubMed ID: 2867063
    [Abstract] [Full Text] [Related]

  • 8. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK, Han EK, Credo B, Jae HS, Pietenpol JA, Scatena CD, Wu-Wong JR, Frost D, Sham H, Rosenberg SH, Ng SC.
    Cancer Res; 2001 Jul 15; 61(14):5480-5. PubMed ID: 11454695
    [Abstract] [Full Text] [Related]

  • 9. Interaction of cryptophycin 1 with tubulin and microtubules.
    Kerksiek K, Mejillano MR, Schwartz RE, Georg GI, Himes RH.
    FEBS Lett; 1995 Dec 11; 377(1):59-61. PubMed ID: 8543019
    [Abstract] [Full Text] [Related]

  • 10. Concomitant decrease of resistance and modifications of the cytoskeleton after all-trans retinoic acid and phorbol ester treatments in a navelbine-resistant bladder carcinoma cell line.
    Debal V, Breillout F, Manfait M.
    Anticancer Res; 1997 Dec 11; 17(2A):1147-54. PubMed ID: 9137463
    [Abstract] [Full Text] [Related]

  • 11. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
    Wagner MM, Paul DC, Shih C, Jordan MA, Wilson L, Williams DC.
    Cancer Chemother Pharmacol; 1999 Dec 11; 43(2):115-25. PubMed ID: 9923816
    [Abstract] [Full Text] [Related]

  • 12. Cryptophycin-induced hyperphosphorylation of Bcl-2, cell cycle arrest and growth inhibition in human H460 NSCLC cells.
    Lu K, Dempsey J, Schultz RM, Shih C, Teicher BA.
    Cancer Chemother Pharmacol; 2001 Dec 11; 47(2):170-8. PubMed ID: 11269744
    [Abstract] [Full Text] [Related]

  • 13. Laulimalide and isolaulimalide, new paclitaxel-like microtubule-stabilizing agents.
    Mooberry SL, Tien G, Hernandez AH, Plubrukarn A, Davidson BS.
    Cancer Res; 1999 Feb 01; 59(3):653-60. PubMed ID: 9973214
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of action cryptophycin. Interaction with the Vinca alkaloid domain of tubulin.
    Smith CD, Zhang X.
    J Biol Chem; 1996 Mar 15; 271(11):6192-8. PubMed ID: 8626409
    [Abstract] [Full Text] [Related]

  • 15. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
    Ranganathan S, McCauley RA, Dexter DW, Hudes GR.
    Br J Cancer; 2001 Sep 01; 85(5):735-40. PubMed ID: 11531260
    [Abstract] [Full Text] [Related]

  • 16. Interaction of microtubules with peroxisomes. Tubular and spherical peroxisomes in HepG2 cells and their alterations induced by microtubule-active drugs.
    Schrader M, Burkhardt JK, Baumgart E, Lüers G, Spring H, Völkl A, Fahimi HD.
    Eur J Cell Biol; 1996 Jan 01; 69(1):24-35. PubMed ID: 8825021
    [Abstract] [Full Text] [Related]

  • 17. Induction of apoptosis by cryptophycin 1, a new antimicrotubule agent.
    Mooberry SL, Busquets L, Tien G.
    Int J Cancer; 1997 Nov 04; 73(3):440-8. PubMed ID: 9359493
    [Abstract] [Full Text] [Related]

  • 18. Effects of microtubule inhibitors on etoposide accumulation and DNA damage in human K562 cells in vitro.
    Yalowich JC.
    Cancer Res; 1987 Feb 15; 47(4):1010-5. PubMed ID: 2879622
    [Abstract] [Full Text] [Related]

  • 19. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
    Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH.
    Mol Pharmacol; 2004 Jan 15; 65(1):77-84. PubMed ID: 14722239
    [Abstract] [Full Text] [Related]

  • 20. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES, Mayer LD.
    Cancer Res; 2000 Jun 01; 60(11):2964-72. PubMed ID: 10850444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.